ExoticRx · exoticrx.com/drugs/topotecan
Topotecan
Hycamtin
Drug Class
Routes
Indications
Mechanism of Action
Semi-synthetic camptothecin analogue that inhibits topoisomerase I by stabilizing the enzyme-DNA complex, preventing DNA religation and causing lethal double-strand breaks.
Side effects & warnings
Severe myelosuppression is dose-limiting. Monitor CBC closely. Dose-reduce in renal impairment. Used investigationally for lymphoma and solid tumors in dogs.
Species with Topotecan dosing data (2 dose rules)
Evidence levels across 2 dose rules
Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.
Backed by a published primary source
- · Withrow & MacEwen's Small Animal Clinical Oncology, 6th Ed
Sample dosing (2 of 2 cited rules)
Free-tier preview — dog and cat dosing. Pro and Student unlock all 2 species including reptiles, birds, pocket pets, livestock, and equine.
| Species | Route | Dose | Frequency | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | IV | 0.75–1 mg/kg | IV over 30 min q24h x 5d, q21d cycles | Weak | Withrow & MacEwen's Small Animal Clinical Oncology, 6th Ed |
| Cat (Domestic) | IV | 0.5–0.75 mg/kg | 0.5-0.75mg/m2 IV q24h x 3-5 days, q21 days | Anecdotal | Withrow & MacEwen's Small Animal Clinical Oncology, 6th Ed |
Upgrade for Full Details
Upgrade to Pro or Student to access full drug details including mechanism of action, warnings, dose ranges, and frequency.
View PlansMore Oncology drugs
Source citations and evidence levels available on the live page. Reference only — verify against current literature before clinical use.